ArticleJournal of cardiovascular translational research2023
The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy.
Hongping Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it